These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 22300579)
1. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. Csősz É; Boross P; Csutak A; Berta A; Tóth F; Póliska S; Török Z; Tőzsér J J Proteomics; 2012 Apr; 75(7):2196-204. PubMed ID: 22300579 [TBL] [Abstract][Full Text] [Related]
2. Diabetic retinopathy: Proteomic approaches to help the differential diagnosis and to understand the underlying molecular mechanisms. Csősz É; Deák E; Kalló G; Csutak A; Tőzsér J J Proteomics; 2017 Jan; 150():351-358. PubMed ID: 27373871 [TBL] [Abstract][Full Text] [Related]
3. Comparison of tear proteins between healthy and early diabetic retinopathy patients. Kim HJ; Kim PK; Yoo HS; Kim CW Clin Biochem; 2012 Jan; 45(1-2):60-7. PubMed ID: 22040812 [TBL] [Abstract][Full Text] [Related]
4. Critical role of mass spectrometry proteomics in tear biomarker discovery for multifactorial ocular diseases (Review). Ma JYW; Sze YH; Bian JF; Lam TC Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760148 [TBL] [Abstract][Full Text] [Related]
5. Glycomic characterization of basal tears and changes with diabetes and diabetic retinopathy. Nguyen-Khuong T; Everest-Dass AV; Kautto L; Zhao Z; Willcox MD; Packer NH Glycobiology; 2015 Mar; 25(3):269-83. PubMed ID: 25303961 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A-I concentration in tears in diabetic retinopathy. Kawai S; Nakajima T; Hokari S; Komoda T; Kawai K Ann Clin Biochem; 2002 Jan; 39(Pt 1):56-61. PubMed ID: 11853190 [TBL] [Abstract][Full Text] [Related]
8. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875 [TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor gene polymorphisms and vitreous proteome changes in diabetic retinopathy. Dyer KH; Silva PS; Sun JK Semin Ophthalmol; 2013; 28(5-6):347-54. PubMed ID: 24138044 [TBL] [Abstract][Full Text] [Related]
10. Combined Methods for Diabetic Retinopathy Screening, Using Retina Photographs and Tear Fluid Proteomics Biomarkers. Torok Z; Peto T; Csosz E; Tukacs E; Molnar AM; Berta A; Tozser J; Hajdu A; Nagy V; Domokos B; Csutak A J Diabetes Res; 2015; 2015():623619. PubMed ID: 26221613 [TBL] [Abstract][Full Text] [Related]
11. [Level of tear endothelin-1 and plasminogen in patients with glaucoma and proliferative diabetic retinopathy]. Pavlenko TA; Chesnokova NB; Davydova HG; Okhotsimskaia TD; Beznos OV; Grigor'ev AV Vestn Oftalmol; 2013; 129(4):20-3. PubMed ID: 24137977 [TBL] [Abstract][Full Text] [Related]
12. Proteomic analysis of retinopathy-related plasma biomarkers in diabetic patients. Lu CH; Lin ST; Chou HC; Lee YR; Chan HL Arch Biochem Biophys; 2013 Jan; 529(2):146-56. PubMed ID: 23220024 [TBL] [Abstract][Full Text] [Related]
13. Multiplatform tear proteomic profiling reveals novel non-invasive biomarkers for diabetic retinopathy. Fan Z; Hu Y; Chen L; Lu X; Zheng L; Ma D; Li Z; Zhong J; Lin L; Zhang S; Zhang G Eye (Lond); 2024 Jun; 38(8):1509-1517. PubMed ID: 38336992 [TBL] [Abstract][Full Text] [Related]
14. [Tear fluid proteome variability in healthy donors]. Bugrova AE; Kononikhin AS; Avtonomov DM; Popov IA; Galetskiĭ DN; Nikolaev EN; Kalamkarov GR Ross Fiziol Zh Im I M Sechenova; 2013 Apr; 99(4):527-36. PubMed ID: 23862393 [TBL] [Abstract][Full Text] [Related]
15. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus]. Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of N-linked glycoproteins in tear fluid of climatic droplet keratopathy by glycopeptide capture and iTRAQ. Lei Z; Beuerman RW; Chew AP; Koh SK; Cafaro TA; Urrets-Zavalia EA; Urrets-Zavalia JA; Li SF; Serra HM J Proteome Res; 2009 Apr; 8(4):1992-2003. PubMed ID: 19714880 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory and angiogenic biomarkers in diabetic retinopathy. Kaštelan S; Orešković I; Bišćan F; Kaštelan H; Gverović Antunica A Biochem Med (Zagreb); 2020 Oct; 30(3):030502. PubMed ID: 32774120 [TBL] [Abstract][Full Text] [Related]
18. Tear Protein Markers for Diabetic Retinopathy and Diabetic Macular Edema - Towards an Early Diagnosis and Better Prognosis. Sharma S; Belenje A; Takkar B; Narula R; Rathi VM; Tyagi M; Rani PK; Narayanan R; Kaur I Semin Ophthalmol; 2024 Aug; 39(6):440-450. PubMed ID: 38643349 [TBL] [Abstract][Full Text] [Related]
19. Risk factors associated with diabetic retinopathy among type 2 diabetes patients at teaching hospital in Malaysia. Abougalambou SS; Abougalambou AS Diabetes Metab Syndr; 2015; 9(2):98-103. PubMed ID: 25470640 [TBL] [Abstract][Full Text] [Related]
20. Identification of tear-based protein and non-protein biomarkers: Its application in diagnosis of human diseases using biosensors. Nandi SK; Singh D; Upadhay J; Gupta N; Dhiman N; Mittal SK; Mahindroo N Int J Biol Macromol; 2021 Dec; 193(Pt A):838-846. PubMed ID: 34728300 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]